📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ThromboDx

1.1 - Company Overview

ThromboDx Logo

ThromboDx

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of blood-based, platelet-powered molecular diagnostics, developed and commercialized through a proprietary technology platform that addresses the need for an easily accessible, minimally invasive source; with offices in Amsterdam, The Netherlands.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ThromboDx

Allegro Diagnostics Logo

Allegro Diagnostics

HQ: United States Website
  • Description: Provider of genomic tests in development to support the diagnosis and management of lung cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allegro Diagnostics company profile →
Salmedix Logo

Salmedix

HQ: United States Website
  • Description: Provider of oncology drug development focused on hematologic malignancies (blood cancers). Primary product SDX-105 is marketed by healthcare professionals in Germany for several types of blood cancers; conducts Phase II clinical trials for SDX-105 in the U.S. and Canada.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salmedix company profile →
Advesya Logo

Advesya

HQ: France Website
  • Description: Provider of therapies for difficult-to-treat cancers, focusing on immuno-oncology and hematological malignancies, leveraging biochemistry and molecular and cellular biology expertise. Offers ADV-101, a topoisomerase I inhibitor antibody-drug conjugate targeting IL-1RAP for esophageal cancer, delivering cytotoxic agents directly to cancer cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Advesya company profile →
OncoEthix Logo

OncoEthix

HQ: Switzerland Website
  • Description: Provider of cancer drug development, advancing a portfolio of three to five promising oncology compounds through clinical development; a private Swiss company founded in 2007.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoEthix company profile →
Forty Seven Logo

Forty Seven

HQ: United States Website
  • Description: Provider of clinical-stage immuno-oncology therapies targeting cancer immune evasion pathways, based on technology licensed from Stanford University. Lead program 5F9 is a monoclonal antibody against the CD47 receptor, a 'don't eat me' signal that cancer cells commandeer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forty Seven company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ThromboDx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ThromboDx

2.2 - Growth funds investing in similar companies to ThromboDx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ThromboDx

4.2 - Public trading comparable groups for ThromboDx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ThromboDx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ThromboDx

What does ThromboDx do?

ThromboDx is a provider of blood-based, platelet-powered molecular diagnostics, developed and commercialized through a proprietary technology platform that addresses the need for an easily accessible, minimally invasive source; with offices in Amsterdam, The Netherlands.

Who are ThromboDx's competitors?

ThromboDx's competitors and similar companies include Allegro Diagnostics, Salmedix, Advesya, OncoEthix, and Forty Seven.

Where is ThromboDx headquartered?

ThromboDx is headquartered in The Netherlands.

How many employees does ThromboDx have?

ThromboDx has 1,000 employees 🔒.

When was ThromboDx founded?

ThromboDx was founded in 2010 🔒.

What sector and industry vertical is ThromboDx in?

ThromboDx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ThromboDx

Who are the top strategic acquirers in ThromboDx's sector and industry

Top strategic M&A buyers and acquirers in ThromboDx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ThromboDx?

Top strategic M&A buyers groups and sectors for ThromboDx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ThromboDx's sector and industry vertical

Which are the top PE firms investing in ThromboDx's sector and industry vertical?

Top PE firms investing in ThromboDx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ThromboDx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ThromboDx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ThromboDx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ThromboDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ThromboDx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ThromboDx?

The key public trading comparables and valuation benchmarks for ThromboDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ThromboDx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ThromboDx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ThromboDx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ThromboDx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ThromboDx's' sector and industry vertical?

Access recent funding rounds and capital raises in ThromboDx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ThromboDx